Dr. Scott Ryan Merriman, MD

Dr. Merriman practices at TriHealth H in Cincinnati, Ohio.

Dr. Merriman's NPI, 1578959524, was assigned on April 7, 2015. Dr. Merriman graduated from Wayne State University School of Medicine in 2015. Dr. Merriman holds Wisconsin license 82560.

Dr. Merriman's primary practice is TriHealth H, at 4685 Forest Ave, Cincinnati, OH 45212 in Hamilton County. The practice phone is (513) 569-6577.

Dr. Merriman's primary practice is TriHealth H in Cincinnati, Ohio. Dr. Merriman is also affiliated with Froedtert Hospital. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Dr. Merriman to 3 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Merriman practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Merriman's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Merriman is licensed in Wisconsin.

CMS data shows 65 Medicare services from Dr. Merriman across 3 procedure codes in 2024, for 68 Medicare patients. Medicare paid $7,228 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 68 Medicare patients who saw Dr. Merriman in 2024. The largest group is 65 to 74, with 26 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Merriman's median patient age at 69, with 54% women.

In 2024, Dr. Merriman wrote 227 Medicare Part D claims for 79 patients. 31% of them were for generic drugs. CMS names the drug for 164 of them, across 7 drugs with 11 or more claims each, at $81,259 in total drug cost. In 2023, CMS named 1,484 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Merriman for performance year 2024, reported through an alternative payment model (APM). Dr. Merriman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 122 general payments to Dr. Merriman from 12 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 99% of the total. GlaxoSmithKline, LLC. paid the most, $512.

Dr. Merriman graduated from Wayne State University School of Medicine in 2015.